Results 1 to 10 of about 54,698,481 (374)

Development and Validation of a New Substance Use Disorder Screening Test Based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)

Journal of Health Science and Medical Research, 2023
Objective: The lack of a screening tool for substance use disorders is a significant problem for health care workers for patient care and referral.
Sukuma Saengduenchai, S. Nilaban, Tanya Singtho, Apichart Ranuwattananon, R. Kalayasiri   +4 more
semanticscholar   +1 more source

Racial and Ethnic Disparities in the Prevalence of Stress and Worry, Mental Health Conditions, and Increased Substance Use Among Adults During the COVID-19 Pandemic — United States, April and May 2020

MMWR. Morbidity and mortality weekly report, 2021
In 2019, approximately 51 million U.S. adults aged ≥18 years reported any mental illness,* and 7.7% reported a past-year substance use disorder† (1).
L. McKnight-Eily, Catherine Okoro, T. Strine, J. Verlenden, N. Hollis, R. Njai, E. W. Mitchell, A. Board, R. Puddy, Craig W. Thomas   +9 more
semanticscholar   +1 more source

Substance Use Among Youth During the COVID-19 Pandemic: a Systematic Review

Current Psychiatry Reports, 2022
To review the literature on the trends in substance use among youth during the coronavirus SARS-CoV-2 (COVID-19) pandemic. The pandemic has given rise to concerns about the mental health and social well-being of youth, including its potential to increase
Hannah M. Layman, I. Thorisdottir, T. Halldorsdottir, I. Sigfusdottir, J. Allegrante, A. Kristjansson   +5 more
semanticscholar   +1 more source

Barriers and Facilitators to Substance Use Disorder Treatment: An Overview of Systematic Reviews

Substance abuse : research and treatment, 2022
objective: This investigation explored the barriers and facilitators to substance use disorder (SUD) treatment in the integrated paradigm. methods: A search technique for barriers and facilitators of SUD treatment was applied to the PubMed and Web of ...
A. Farhoudian, E. Razaghi, Zahra Hooshyari, A. Noroozi, A. Pilevari, A. Mokri, Mohammad Reza Mohammadi, M. Malekinejad   +7 more
semanticscholar   +1 more source

Assessment of Annual Cost of Substance Use Disorder in US Hospitals

JAMA Network Open, 2021
Key Points Question How much does substance use disorder cost each year in US hospitals? Findings In this economic evaluation of 124 573 175 hospital emergency department encounters and 33 648 910 hospital inpatient encounters, the annual medical cost ...
Cora Peterson, Mengyao Li, Likang Xu, Christina A Mikosz, Feijun Luo   +4 more
semanticscholar   +1 more source

A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability Study

Journal of Medical Internet Research, 2021
Background Misuse of substances is common, can be serious and costly to society, and often goes untreated due to barriers to accessing care. Woebot is a mental health digital solution informed by cognitive behavioral therapy and built upon an artificial ...
J. Prochaska, Erin A. Vogel, Amy Chieng, M. Kendra, M. Baiocchi, Sarah Pajarito, A. Robinson   +6 more
semanticscholar   +1 more source

Genetics of substance use disorders: a review

Psychological Medicine, 2021
Substance use disorders (SUDs) are prevalent and result in an array of negative consequences. They are influenced by genetic factors (h2 = ~50%). Recent years have brought substantial progress in our understanding of the genetic etiology of SUDs and ...
J. Deak, Emma C. Johnson
semanticscholar   +1 more source

Experiences of violence during the COVID-19 pandemic among people who use drugs in a Canadian setting: a gender-based cross-sectional study

BMC Public Health, 2023
Objectives People who use drugs (PWUD) experience disproportionately high rates of violent victimization. Emerging research has demonstrated that the COVID-19 pandemic has exacerbated violence against some priority populations (e.g., women), however ...
Anmol Swaich, Lindsey Richardson, Zishan Cui, Kora DeBeck, M-J Milloy, Thomas Kerr, Kanna Hayashi   +6 more
doaj   +1 more source

The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting

Addiction Science & Clinical Practice, 2021
Background While patient-reported treatment dissatisfaction is considered an important factor in determining the success of substance use disorder treatment, the levels of dissatisfaction with opioid agonist therapies (OAT) and its relationship with the ...
Lindsay Mackay, Thomas Kerr, Nadia Fairbairn, Cameron Grant, M.-J. Milloy, Kanna Hayashi   +5 more
doaj   +1 more source

Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020

MMWR. Morbidity and mortality weekly report, 2020
The coronavirus disease 2019 (COVID-19) pandemic has been associated with mental health challenges related to the morbidity and mortality caused by the disease and to mitigation activities, including the impact of physical distancing and stay-at-home ...
Mark E Czeisler, R. Lane, Emiko Petrosky, J. Wiley, Aleta Christensen, R. Njai, M. Weaver, R. Robbins, E. Facer-Childs, L. Barger, C. Czeisler, M. Howard, S. Rajaratnam   +12 more
semanticscholar   +1 more source